Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.69
+0.50 (8.08%)
At close: Feb 6, 2026, 4:00 PM EST
6.68
-0.01 (-0.15%)
After-hours: Feb 6, 2026, 7:05 PM EST
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $143.78 million as of February 6, 2026. Its market cap has increased by 120.96% in one year.
Market Cap
143.78M
Enterprise Value
101.35M
1-Year Change
120.96%
Ranking
Category
Stock Price
$6.69
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $143.78M, an increase of 116.24%. That is a compound annual growth rate of 18.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 143.78M | 15.94% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jyong Biotech | 145.34M |
| Corbus Pharmaceuticals Holdings | 143.97M |
| Vaxart | 143.96M |
| Caribou Biosciences | 143.47M |
| Nkarta | 140.28M |
| Acumen Pharmaceuticals | 138.71M |
| Rani Therapeutics Holdings | 136.71M |
| Elicio Therapeutics | 136.31M |